(c) As expected, the traditional anti-atherosclerosis drug pitavastatin alleviated the progression of atherosclerosis and promoted the stability of atherosclerotic plaques by ameliorating the vascular aging, inhibiting inflammation action and oxidative stress, and this effect may be exerted partly through the modulation of GLP-1/APN axis. This evidence concerns the gene GLP1R and atherosclerosis.